2801 - 2810 of 7916 Results
Title
Year
-
OPENTitle: SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00468-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00468-xCitation Count: 12
-
RESTRICTEDTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 31
- Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s disease2021OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 28
-
RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 4
- Coexistence of deep brain stimulators and cardiac implantable electronic devices: A systematic review of safety2021RESTRICTEDTitle: Coexistence of deep brain stimulators and cardiac implantable electronic devices: A systematic review of safetyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 129End Page: 135Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.018Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3638884/viewCitation Count: 2
- Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies2021OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 11
-
OPENTitle: Genetic diversity of axon degenerative mechanisms in models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105368End Page: 105368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105368Citation Count: 18
- Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial2021OPENTitle: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1733End Page: 1733Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28659Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28659Citation Count: 1
-
OPENTitle: LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 103Issue #:Start Page: 142.e1End Page: 142.e5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178224Citation Count: 16
-
RESTRICTEDTitle: Managing Advanced Parkinson DiseaseJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 34Issue #: 4Start Page: 289End Page: 300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/08919887211018277Citation Count: 6